Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin-like growth factor (IGF) 1 and interleukin (IL) 1a on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte-like cells (DES4
of the regulation of chondrocyte gene expression and cell survival to be studied in cell culture.
Chondrocytes synthesize an elaborate extracellular matrix rich in collagen type II, aggrecan and link protein and smaller amounts of collagen types IX and XI. However, during the process of endochondral ossification, chondrocytes in the growth plate pass through a number of stages of differentiation before they cease to proliferate, become hypertrophic and start to synthesize type X collagen w9x. In culture, isolated primary mammalian chondrocytes steadily lose the expression of the cartilage-specific genes such as those encoding collagens and proteoglycans, although the slow progressive rate of decline suggests that cell shape alone is not a factor that determines the chondrocyte phenotype w10-16x. However, the loss of chondrocyte differentiated characteristics in vitro has been linked to the reduced expression of chondrocyte-specific transcription factors, principally Sox-9 w16, 17x.
Sox-9 is a transcription factor with a high mobility group DNA-binding domain similar to SRY, the testisdetermining factor w18x, and is a member of a larger family of Sox genes. Sox-9 expression accompanies chondrocyte differentiation w17x. It is coexpressed with collagen type II (Col2a1) during chondrogenesis in the mouse and in cultured chondrocytes w15-21x. Ectopic expression of Sox-9 transactivates both a Col2a1-driven reporter gene and the endogenous Col2a1 gene in transgenic mice w20x and in cultured chondrocytes and embryonic cells w15, 16x. Recently Sox-9 was shown to enhance aggrecan gene promoteruenhancer activity w22x. In humans, heterozygous mutations in the Sox9 gene cause campomelic dysplasia, a malformation syndrome associated with sex-reversal and abnormal skeletal development, suggesting an essential role for Sox-9 in skeleton formation w23-26x. In mouse embryo chimaeras, Sox9 2u2 mutant cells were blocked in their differentiation to become chondrocytes and persisted as mesenchymal cells that were unable to express chondrocyte-specific markers, such as collagen types II, IX and XI and aggrecan, which shows that Sox-9 is an essential factor for chondrocyte differentiation w27x.
Numerous studies have shown that the regulation of the synthesis of cartilage-specific molecules, such as collagens and proteoglycans in cultured chondrocytes and cartilage explants w28-33x or in undifferentiated mesodermal progenitors w5x, is influenced by a variety of growth factors and cytokines. Chondrocytes are capable of producing and responding to a large number of peptide growth factors and cytokines, including insulin-like growth factor 1 (IGF-1) and interleukin 1 (IL-1) w28-33x, and these results suggest that an imbalance of anabolic and catabolic growth factors and cytokines is likely to effect the chondrogenic phenotype. There is also evidence that growth factors and cytokines are required for chondrocyte survival, as in their absence chondrocytes undergo morphological changes and die by apoptosis w34-38x.
Despite these studies, little is yet known of how anabolic and catabolic cytokines such as IGF-1 and IL-1 affect chondrocyte survival or the mechanism(s) whereby they influence the expression of the chondrocyte phenotype. In the present work, these questions were investigated using a chondrocyte-like cell line produced by carcinogen-immortalization of normal Syrian hamster embryo cells w6-8x. Culture of these cells in monolayer showed that at early passage these cells expressed chondrocyte-specific genes in a cell densityand serum-dependent manner w8, 12x. The present results show that, as with primary chondrocytes, the expression of these extracellular matrix genes is differentially modulated by specific cytokines. IGF-1 and IL-1a had opposite and antagonistic effects on gene expression and cell survival. While IL-1a was a potent inhibitor of the chondrocyte phenotype and down-regulated the expression of the chondrogenic transcription factor Sox-9, IGF-1 up-regulated Sox-9 expression and relieved the IL-1a-induced inhibition of the chondrocyte phenotype. Thus, we suggest that IGF-1 and IL-1a, both of which may be important in degenerative diseases of cartilage, both modulate chondrocyte survival and differentiation through changes in the expression of the Sox9 gene.
Materials and methods
Cell culture DES4 supB + clone 2 (referred to as DES4 + .2 hereafter) w6x and 10W supB + clone 1 (referred to as 10W + .1 hereafter) w7x are two carcinogen-immortalized, nontumorigenic Syrian hamster embryonic chondrocyte-like cell lines derived from early-passage diploid Syrian hamster embryo cells following treatment with diethylstilboestrol and asbestos respectively. The cells were cultured in Minimal Essential Medium supplemented with 10% fetal calf serum (FCS), 1% (vuv) non-essential amino acids, 1.4 mM L-glutamine, 100 unitsuml penicillin and 100 mguml streptomycin (referred to as complete growth medium) in tissue culture dishes at 378C under 5% carbon dioxide.
Treatment of chondrocyte cell lines with IL-1a, IGF-1 and 5-azacytidine Early-passage DES4 + .2 and 10W + .1 cells were split at 1 : 16 and cultured in complete growth medium for 3 days to reach 50-60% subconfluency or for 4-5 days to become confluent. The medium was changed from the subconfluent and confluent cells to either fresh complete growth medium or serum-free growth medium with or without 5 nguml human recombinant IL-1a or 50 nguml human recombinant IGF-1 or both cytokines together (Gibco-BRL Life Technologies, Paisley, UK), at the given concentrations, for 1 or 14 h before extraction of RNA or low molecular weight DNA, as indicated in the figure legends.
Serum-stimulated or serum-free subconfluent or confluent cultures of early-passage DES4
+ .2 cells were treated with 4.10 mM 5-azacytidine (5-aza-CR) (Sigma, Poole, Dorset, UK) for 14 h. The following day the medium was replaced with fresh medium containing 4.10 mM 5-aza-CR. Twenty-four hours later, floating cells were harvested and low molecular weight DNA was isolated.
Isolation of RNA and Northern blot analysis Total cellular RNA was prepared using the LiCl-urea method w39x from subconfluent or confluent monolayers of early passage DES4
+ .2 cells in the presence or absence of 10% FCS and IL-1a or IGF-1, or both cytokines together, as indicated in the figure legends. Total RNA (30 mg) was subjected to Northern blot hybridization analysis using 32 P-labelled specific probes as described previously w13x. The probes used were a 1.65-kilobase (kb) EcoRI human procollagen a1(I) cDNA fragment from HF-677 w40x, a 0.6-kb EcoRIHindIII fragment carrying exon 1 of the mouse procollagen a1(II) gene from pELIII w41x, a 1.55-kb EcoRIHindIII fragment carrying exon 2 of the human procollagen a1(II) gene from pTII (a kind gift of Drs D. Prockop and L. Ala-Kokko, Thomas Jefferson University, USA), a 0.75-kb EcoRI rat collagen a1(IX) cDNA fragment from pKT1643 w42x, a 0.7-kb HindIII cDNA fragment encoding most of the C-terminal noncollagenous domain and part of the 39 untranslated region of the human collagen type X cDNA from pUChColX w43x, a 2.1-kb EcoRI human aggrecan cDNA fragment from pKS.H4 w44x, a 1.3-kb human versican cDNA fragment from PG-350 encompassing the 39 region of human versican (Bioquote, York, UK), a 1.8 kb EcoRI human link protein cDNA fragment from pKS8.1D3 w45x, a 1.3-kb EcoRI human biglycan cDNA fragment from P16 w46x and a 255-base pair (bp) EcoRI-HindIII mouse Sox9 cDNA fragment from pKSmSox9 w16x.
Reverse transcriptase-polymerase chain reaction (RT-PCR) Total RNA isolated from early-(pdl 4) and late (pdl 12)-passage confluent DES4
+ .2 cells grown as monolayers was reverse-transcribed using Super RT grade reverse transcriptase (HT Biotechnology, Cambridge, UK). The reaction was performed in a 20-ml volume containing 2 mg of total RNA, 10 mM dithiothreitol, 1 mM dNTPs, 10 ng random primers pd(N) 6 in 1 3 RT reaction buffer (50 mM Tris-HCl, pH 8.3, 40 mM KCl, 6 mM MgCl 2 ) and 10 units of reverse transcriptase. The tubes were incubated on a Hybaid Combi (TR2) thermal reactor (Thermo Hybaid, Ashford, UK) at 378C for 1 h. After heat-inactivation for 5-min at 958C, the cDNAs were amplified in a reaction volume of 100 ml. The reaction contained 2 ml of cDNA, 1 mM MgCl 2 , 200 mM dNTPs, 0.5 ml of Taq polymerase (Promega, Southampton, UK), 1 mM of each forward and reverse primer to collagen type II or aggrecan in 13 reaction buffer.
The primer to collagen type II was 59-GTACC-GATCACAGAAGACCTCC-39 and 59-TGCAGATC-CTGGAGTGACTG-39 and the primer to aggrecan was 59-GGTCCCATACTCCCACAGTTGGC-39 and 59-GGAATCCCACTAACATATCCCCC-39.
PCR reactions were carried out on a Hybaid Combi (TR2) thermal reactor as follows: one cycle of 958C (2 min) and 728C (2 min), 35 cycles of 958C (1 min), 558C (1 min) and 728C (1 min) followed by one cycle of 728C (5 min) and 308C (1 min). The PCR reaction products were analysed on 1% agarose gels stained with ethidium bromide. The markers used were a 50-2000 bp DNA ladder (Amersham International, Little Chalfont, UK).
Isolation of chondrocyte-specific molecules and Western blot analysis The culture media from early-and late-passage DES4
+ .2 cells cultured as monolayers were collected and processed for the isolation of collagens, proteoglycans and link protein and for immunoblot analysis as described previously w13x. Briefly, collagens or link protein were resolved on 8% sodium dodecyl sulphate (SDS)-polyacrylamide gels, blotted onto nitrocellulose and probed with a mouse monoclonal anti-human collagen type II antibody (Chemicon International Ltd, Harrow, UK) and the mouse monoclonal antibody 8-A-4, raised against rat chondrosarcoma link protein, respectively. Proteoglycans were separated on a polyacrylamide composite gel under dissociative conditions and blotted onto Immobilon nylon membrane (Millipore Ltd, Watford, UK). The filter was incubated for 1 h at room temperature with 0.05 unitsuml ABC chondroitinase (Sigma, Dorset, UK), washed with phosphatebuffered saline (PBS), blocked with 3% low-fat dried milkuPBS and probed with an anti-human aggrecan hyaluronic acid binding region antiserum diluted at 1 : 1000. Collagen type II, aggrecan and link protein were visualized using an ECL Western blot detection kit (Amersham International, Little Chalfont, UK).
Isolation of low molecular weight DNA and analysis of DNA fragmentation Early-passage DES4 + .2 and 10W + .1 cells were cultured as monolayers under low or high cell density in the presence or absence of 10% FCS with or without cytokines, or after treatment with 5-aza-CR, as indicated in Fig. 5 . The culture medium containing floating cells was collected from four 90-mm dishes after 24 h and placed on ice. The monolayers were washed with 5 ml calcium-and magnesium-free PBS (referred to as PBS hereafter) and the washes were collected and combined with the culture medium. The floating cells were pelleted by centrifugation at 48C for 5 min at 1500 r.p.m. The cell pellets were resuspended in 1.5 ml of PBS containing 1 mM ethylenediamine tetraacetic acid (EDTA) (pH 8.0) and centrifuged at 48C for 5 min at 6000 r.p.m. After a second wash as above, the cell pellet was resuspended in 400 ml of 0.6% SDSu1 mM EDTA (pH 8.0) and the lysate was mixed briefly by inversion. After standing for 10 min on ice, the lysate was mixed briefly and 100 ml of 5 M NaCl was added to give a final concentration of 1 M NaCl. The solution was mixed by inversion and left overnight at 48C. After centrifugation at 48C for 20 min at 6500 r.p.m., the supernatant was transferred to a clean tube and the low molecular weight DNA was precipitated by the addition of two volumes of ethanol at 2208C overnight. The DNA was pelleted by centrifugation at 48C for 30 min at 13 000 r.p.m., washed with 70% ethanol, dried under vacuum and dissolved in sterile distilled water. For in vitro labelling of the DNA, 3 mg of DNA in 20 ml was mixed with 3 ml of 100 mM Tris-HCl (pH 7.5), 50 mM MgCl 2 , 0.1 mCi w 32 PxdCTP and 5 U Klenow polymerase in a final reaction volume of 30 ml and incubated at room temperature for 25 min. The reaction was terminated by the addition of 0.6 ml of 0.5 M EDTA (pH 8.0) w47x. The DNA was analysed by electrophoresis on agarose gel containing 1.8% ethidium bromide for 3 h at 100 V. The gel containing labelled DNA was then dried under vacuum without heat and exposed to autoradiography.
Results

Characterization of Syrian hamster embryonic chondrocyte-like cells
The two preneoplastic Syrian hamster embryonic cell lines, DES4
+ .2 and 10W + .1 w6, 7x, have been shown previously to express chondrocyte markers, such as collagen type II and type IX mRNA, suggesting that carcinogen-induced immortalization selected for chondrocyte-like cell lines from a mixed embryo cell population w8, 12x. To further characterize one of these cell lines, DES4
+ .2, proteins were extracted from confluent early-passage (pdl 4) and late-passage (pdl 12) cells grown as monolayers and subjected to immunoblot analysis using antibodies specific for the chondrocyte markers collagen type II, aggrecan and link protein (Fig. 1A) . Whereas in early passage the DES4 + .2 cells synthesized collagen type II, aggrecan and link protein, in late passage they failed to synthesize collagen type II, while aggrecan synthesis was decreased and link protein synthesis remained unaffected (Fig. 1A) . The chondrocyte-like phenotype exhibited by earlypassage cells was stable during 10-12 population doublings, but at later passage collagen II and aggrecan were detectable only by RT-PCR (Fig. 1B) .
Total RNA was extracted from confluent early-and late-passage cells grown as monolayers and subjected to Northern blot hybridization analysis using a variety of chondrocyte markers as probes. Early-passage, but not late-passage, DES4
+ .2 cells were found to express collagen types II and IX, collagen a1(I) and collagen X, aggrecan, biglycan and link protein (Figs 2 and 3), suggesting that these embryonic cells have a chondrogenic potential that declines with passage w9x. The simultaneous expression of collagen types II and IX and collagen type X, a marker of cellular hypertrophy w9x, suggests that these cells may express a prehypertrophic chondrocyte-like phenotype.
Expression of chondrocyte-specific collagens depends on cell density and serum To study how the expression of chondrocyte-specific collagen genes such as collagen types II and IX was modulated by different culture conditions and specific cytokines, early-passage DES4 + .2 cells were cultured as monolayers at low or high cell density in the presence or absence of 10% FCS. Northern blot analysis of the expression of collagen type a1(II) ( Fig. 2A) and collagen type a1(IX) (Fig. 2B) showed that it was dependent on cell density and on the presence of serum. Stimulation of subconfluent or confluent cultures with serum for 1 h increased ( Fig. 2A and B, lanes 1 and 3) the expression of collagen types II and IX compared with subconfluent or confluent cultures incubated in serum-containing medium for 14 h ( Fig. 2A and B, lanes 2 and 4) . The expression of both cartilage-specific collagens was much less in serum-containing subconfluent ( Fig. 2A and B, lanes 1 and 2) than in the corresponding confluent cultures ( Fig. 2A and B, lanes 3 and 4) . Similarly, the mRNA levels of collagen types II and IX were lower in the subconfluent ( Fig. 2A and B , lane 5) than in the confluent ( Fig. 2A and B, lane 6) cells cultured in the absence of serum. Furthermore, densitometric analysis showed that the expression of collagen types II and IX in cells cultured in the presence of serum was higher than in cells cultured in the absence of serum ( Fig. 2A and B; compare lanes 1 and 2 with lane 5 and lanes 3 and 4 with lane 6).
In the confluent DES4 + .2 cells cultured in the presence of serum, collagen type a1(IX) was detected in two transcripts of about 4.5 and 4.2 kb (Fig. 2B, lanes 3  and 4) , whereas in serum-stimulated subconfluent cells (Fig. 2B, lanes 1 and 2) and in serum-free cells (Fig. 2B , lanes 5 and 6) only the 4.5-kb mRNA was present. Two collagen type a1(IX) transcripts have been detected previously in several Syrian hamster chondrocyte-like cell lines w8x and also in chicken embryonic sternal cartilage w48, 49x, but the significance of their absence in subconfluent and serum-free cells in the present work remains to be determined.
Hybridization of the Northern blot with a human collagen a1(I) cDNA fragment (Fig. 2C) produced two transcripts, of 7.5 and 5.9 kb. The pattern of expression of collagen a1(I) was serum-and density-dependent. The expression of collagen type I was higher in the serumstimulated, confluent cells (Fig. 2C, lanes 3 and 4) than in the subconfluent DES4 + .2 cells (Fig. 2C , lanes 1 and 2) and was very low or undetectable in the serum-free, subconfluent and confluent cells (Fig. 2C, lanes 5 and 6) . The expression of type X collagen, as a marker of chondrocyte hypertrophy, appeared to be low (Fig. 2D) , but it was cell density-and serum-dependent, as was that of the other collagens.
Expression of chondrocyte-specific aggrecan and link protein is cell density-and serum-dependent The expression of cartilage aggrecan and link protein genes was studied to assess if they followed the same pattern of expression as cartilage collagens. The DES4 + .2 cells expressed an 8.5-kb aggrecan mRNA under all culture conditions tested (Fig. 3A, lanes 1-6) . Like the expression of cartilage collagens (Fig. 2) , the expression of aggrecan was serum-and cell densitydependent. Aggrecan expression was higher in the serumstimulated, confluent cells (Fig. 3A, lanes 3 and 4) than in the subconfluent cells (Fig. 3A, lanes 1 and 2) , and also higher than in cells cultured in serum-free media (Fig. 3A, lanes 5 and 6) . Versican w13, 50x was also expressed by DES4 + .2 cells, but much longer exposures were required to detect it (not shown).
Chondrocytes also express small proteoglycans, such as biglycan and decorin w51-53x. The DES4 + .2 cells expressed a 2.7-kb biglycan mRNA (Fig. 2B ) in a cell density-and serum-dependent manner, but the changes in its expression were less profound than those in the expression of aggrecan (Fig. 2B, lanes 1-6) .
Northern blot analysis using a human link protein cDNA fragment as probe (Fig. 3C) showed three link protein transcripts, as reported previously in mouse w11x, rat w54x and human w13x chondrocytes. The pattern of expression of link protein in low-density (Fig. 3C , lanes 1 and 2) and high-density (Fig. 3C, lanes 3 and 4) cultures in response to serum was similar to that of aggrecan (Fig. 3A) and the proportions of transcripts of different sizes did not appear to change.
Modulation of cartilage-specific gene expression by IL-1a and IGF-1
The rapid induction of cartilage-specific gene expression by serum prompted us to investigate the effects of the cytokines IGF-1 and IL-1a, both of which have been reported previously to play a role in chondrocyte matrix production and in growth and differentiation. Confluent monolayers of early-passage DES4
+ .2 cells cultured with IL-1a or IGF-1 were analysed by Northern blot hybridization for the expression of cartilage-specific genes (Figs 2 and 3) . Addition of IL-1a reduced dramatically the mRNA levels of collagen types II, IX and X (Fig. 2A, B and D, lane 7) , aggrecan and link protein ( Fig. 3B and C, lane 7) compared with serumfree control cultures (Figs 2 and 3, lane 6) . In contrast, the expression of collagen a1(I) increased in response to IL-1a (Fig. 2C, lane 7) and the expression of biglycan was unaffected (Fig. 3B, lane 7) compared with controls ( Figs 2C and 3B, lane 6) .
Whereas treatment of confluent, serum-free cultures of DES4 + .2 with IGF-1 resulted in a significant increase in the mRNA levels of collagen types II (Fig. 2A, lane 8) and IX (Fig. 2B, lane 8) , aggrecan (Fig. 3A, lane 8), biglycan (Fig. 3B, lane 8) and link protein (Fig. 3C, lane 8) , it had no effect on the expression of collagen a1(I) (Fig. 2C, lane 8) or collagen type X (Fig. 2D, lane 7) compared with controls (Figs 2  and 3, lane 6) .
However, when both cytokines (IL-1a and IGF-1) were present, IGF-1 relieved the IL-1a-induced suppression of chondrocyte-specific gene expression (Figs 2 and  3, lane 9 ). In the presence of both cytokines, at the concentrations used there was a significant increase in the mRNA levels of collagen type II (Fig. 2A, lane 9) , collagen type IX (Fig. 2B, lane 9) , aggrecan (Fig. 3A , lane 9), link protein (Fig. 3C, lane 9 ) and, to a lesser degree, biglycan (Fig. 3B, lane 9 ) compared with cultures treated with IL-1a alone (lane 7 in Fig. 2A and B and Fig. 3A-C) . In contrast, the expression of collagen a1(I) (Fig. 2C, lane 9) in the presence of IL-1a and IGF-1 was less than in cells treated with IL-1a alone (Fig. 2C, lane 7) . Together in serum-free confluent cultures, IL-1a and IGF-1 did not appear to increase significantly the expression of collagen a1(X) (Fig. 2D,  lane 9) . Hence, IL-1a and IGF-1 had opposite and antagonistic effects, IL-1a acting as an inhibitor and IGF-1 acting as an inducer of chondrocyte-specific gene expression.
Inhibition of Sox9 expression by IL-1a is relieved by IGF-1
In order to gain some insight of the mechanism(s) whereby IL-1a and IGF-1 affect the expression of the chondrocyte phenotype, we investigated the expression of the chondrogenic transcription factor gene Sox9 in response to these cytokines acting alone or together. Expression of Sox9 was cell-density dependent (Fig. 4 , lanes 2 and 3) but serum appeared to have little effect on confluent cells (Fig. 4, lanes 1 and 3) . IL-1a-treatment of DES4 + .2 cells markedly inhibited the expression of Sox9 (Fig. 4, lane 4) , whereas IGF-1 up-regulated its expression (Fig. 4, lane 5) and partially relieved the IL-1a-induced down-regulation of Sox9 (Fig. 4, lane 6) . Densitometric analysis using Kodak DC120 zoom digital camera and a gel analyser software (Biosure Ltd, Athens, Greece) showed a four-fold increase in the expression of Sox9 when IGF-1 and IL-1a were added together (Fig. 4, lane 6) , compared with that in the cells treated with IL-1a alone (Fig. 4, lane 4) . Interestingly, the expression of Sox9 was absent in late-passage DES4 + .2 cells (Fig. 4, lane 7) and IGF-1-treatment was not sufficient to induce it in these cells (Fig. 4, lane 8) . These changes in Sox9 expression thus paralleled the changes in the expression of the chondrocyte-specific markers such as collagen types II and IX (Fig. 2) , aggrecan and link protein (Fig. 3) .
Induction of apoptosis in cultured chondrocytes and the effect of IL-1a, IGF-1 and 5-aza-CR on cell survival In order to detect apoptosis, DNA was isolated from floating DES4
+ .2 and 10W + .1 cells growing under the different culture conditions. After radioactive labelling and agarose gel electrophoresis, the characteristic DNA ladders of cells undergoing apoptosis were detected (Fig. 5) . Whereas subconfluent (Fig. 5, lanes 1 and 2) and confluent (Fig. 5, lane 3 ) cells cultured as monolayers in the presence of serum did not undergo apoptosis, cells cultured under serum-free conditions at high cell density (Fig. 5, lanes 4 and 12) , but not at low cell density (Fig. 5, lane 11) , showed extensive DNA fragmentation, with 180-bp nucleosome-size fragments characteristic of cells undergoing apoptosis.
Whereas addition of IL-1a to serum-free, confluent DES4 + .2 and 10W + .1 cells cultured as monolayers did not increase apoptosis (Fig. 5, lanes 5 and 13  respectively) , addition of IGF-1 (Fig. 5, lanes 6 and 14  respectively) reduced the extent of DNA fragmentation compared with the untreated controls (Fig. 5, lanes 4  and 12 respectively) . The addition of both IL-1a and IGF-1 to serum-free confluent monolayer cultures of DES4 + .2 cells (Fig. 5, lane 7) and 10W + .1 cells (Fig. 5, lane 15) showed that IL-1a, which when acting alone had no effect on apoptosis, opposed slightly the IGF-1-mediated positive effect on cell survival. This was noticeable in 10W + .1 cells (Fig. 5 , compare lane 14 with 15) but not in DES4 + .2 ( + .1 (lanes 11-15) cells cultured under the different conditions, radiolabelled with w 32 PxdCTP, fractionated on a 1.8% agarose gel, dried and exposed to autoradiography. DES4
+ .2 cells were cultured at low cell density and stimulated with FCS for 1 h (lane 1) or with 10% FCS for 14 h (lane 2). DES4
+ .2 cells were cultured at high cell density and stimulated with 10% FCS for 14 h (lane 3). DES4
+ .2 and 10W + .1 cells were cultured at high cell density in the absence of serum (lanes 4 and 12 respectively) and in the presence of IL-1a (lanes 5 and 13 respectively) or in the presence of IGF-1 (lanes 6 and 14, respectively). DES4
+ .2 and 10W + .1 cells (lanes 7 and 15 respectively) were cultured at high cell density in serum-free medium and in the presence of IL-1a and IGF-1. DES4
+ .2 cells were cultured at high cell density and stimulated with FCS for 1 h (lane 8) or 14 h (lane 9) or incubated in the absence of serum (lane 10) and then treated with 5-aza-CR for 24 h. 10W + .1 cells were cultured at low cell density in the absence of serum (lane 11). Exposure was for 10 min at room temperature. with 7). Thus IGF-1, even in the presence of IL-1a, was capable of increasing cell survival compared with serum-free, confluent, untreated (Fig. 5, lanes 4 and 12) and IL-1a-treated cells (Fig. 5, lanes 5 and 13) .
Several factors have been reported to induce apoptosis in cultured chondrocytes w35-38, 55-59x. Treatment of confluent DES4
+ .2 cells with 5-aza-CR, a DNA-demethylating agent, induced apoptosis irrespective of the presence or absence of serum (Fig. 5,  lanes 8-10) . However, the extent of DNA fragmentation appeared to be higher in the cells stimulated with serum for 1 h (Fig. 5, lane 8) than in those stimulated with serum for 14 h (Fig. 5, lane 9) and those cultured in serum-free medium (Fig. 5, lane 10) .
Discussion
A Syrian hamster embryonic chondrocyte-like cell line, DES4
+ .2 w6, 8, 12, 55, 56x, was used to investigate the effects of culture conditions, serum, cell density and specific cytokines (IGF-1 and IL-1a) on chondrocytespecific gene expression and cell survival. The main novel findings were that chondrocyte-specific gene expression was cell density-and serum-dependent and that two specific cytokines, IL-1a and IGF-1, had opposite and antagonistic effects on the expression of chondrocyte markers and cell survival. The effects of these two cytokines on the chondrocyte phenotype correlated with changes in the expression of Sox9, a key chondrocyte-regulatory transcription factor gene.
Early-but not late-passage DES4 + .2 cells cultured as monolayers expressed chondrocyte-specific markers, such as collagen types II, IX and X (Fig. 2) , aggrecan, biglycan and link protein (Fig. 3) in a cell density-and serum-dependent manner. In later-passage cells, synthesis of collagen type II, aggrecan and link protein was absent, reduced and remained unaffected respectively. Failure of the ability of late-passage cells to express chondrocyte differentiation markers was linked to the loss of their ability to express tumour suppressor gene function, which may be involved in the regulation of chondrocyte differentiation w8, 12x. Collagen type a1(II) mRNA was present as a 5.2-kb transcript in cells cultured under all the different conditions ( Fig. 2A) . However, type II procollagen mRNA can be alternatively spliced to give two mRNA species w60, 61x. The type IIA mRNA species contains exon 2, encoding a cysteine-rich domain in the amino propeptide, and is expressed in several human w62x and mouse w63x tissues, whereas type IIB, which lacks exon 2, is the major transcript in cartilage w60-63x. Although the cells used in the present study were of embryonic origin, no expression of collagen type IIA was detectable by Northern blot hybridization analysis using a human exon 2-specific probe. This showed that DES4 + .2 cells predominantly expressed type IIB, the cartilage-specific procollagen mRNA. In addition, DES4
+ .2 cells expressed collagen a1(I) and low levels of collagen type X mRNA, a marker of chondrocyte hypertrophy, suggesting that the cells may be in a prehypertrophic state of maturation. Furthermore, the expression of collagen type X, and hence progression towards cellular hypertrophy, could be minimized or prevented by culturing the cells at low cell density and in the absence of serum, which is consistent with previous reports w64, 65x. Evidence for the synthesis of the protein products of the major chondrocyte-specific genes, such as collagen type II, aggrecan and link protein, by early-passage DES4
+ .2 cells suggests that these cells grown as monolayers retained their differentiation characteristics at least for several passages. Furthermore, the cell density-and serum-dependent expression of all the cartilage-specific genes shows that culture conditions have a major affect on the transcription of these genes. The results presented here show that these effects correlate with the expression of Sox9 (Fig. 5) . This is consistent with studies showing that transfection of Sox9 enhances the expression of collagen types II and IX w15, 16, 19, 20x and aggrecan w22x and that Sox9 expression is essential for chondrogenesis w17, 27, 66, 67x. Thus, DES4
+ .2 cells required growth factors for the expression of their differentiated characteristics, which may be provided in serum by other cell types or may be produced by chondrocytes themselves w30, 31x. Moreover, brief stimulation of the cells with serum was sufficient to enhance the expression of all the genes investigated, showing that a rapid response was involved.
The major action of serum on the expression of chondrocyte-specific genes may be due to its IGF-1 content. Investigation of the effects of two specific cytokines, IGF-1 and IL-1a, which have been implicated in chondrocyte growth and differentiation w30, 31x as well as in pathological conditions of cartilage w28x, showed that they had opposite and antagonistic effects on chondrocyte-specific gene expression. Whereas IL-1a suppressed the basal mRNA levels, IGF-1 up-regulated the expression of all the chondrocyte-specific genes investigated. Similar results were also obtained with IL-1b, at least on collagen type II and aggrecan gene expression (not shown). Furthermore, IGF-1 relieved the IL-1a-induced inhibition of chondrocyte-specific gene expression at the concentration used. The opposite and antagonistic effects of IL-1a and IGF-1 on the expression of the chondrocyte phenotype paralleled changes in the expression of the Sox9 gene. Whereas IGF-1 has been shown previously to induce the transcription and synthesis of chondrocyte-specific markers, IL-1 has been shown to decrease proteoglycan and collagen type II synthesis in chondrocytes and in explant cultures of articular cartilage w28-33, 68x. In particular, IL-1a or IL-1b has been shown to suppress the transcription of human collagen type IX w69x and collagen type II in cultured human w69, 70x, rat, rabbit w71x and mouse w72x chondrocytes, an effect shown previously to be mediated by a transcriptional mechanism w71x. Recent studies have reported that IL-1b inhibits the expression of the chondrocyte phenotype by markedly down-regulating the expression of Sox9 and that transfection of a Sox9 expression vector in chondrocytes overcomes the inhibitory effect of IL-1b on the activity of a Col2a1 enhancer construct w72x. This is consistent with the present studies, which show that IGF-1 overcomes the inhibitory effect of IL-1a on Sox9 expression, thus maintaining the chondrocyte phenotype. Late-passage cells that did not express the chondrocyte phenotype failed to express Sox9, and IGF-1 was unable to induce Sox9 expression in these cells. Given the recent genetic evidence for the role of Sox-9 in chondrocyte differentiation w17, 27, 66, 67x and the fact that IL-1a and IGF-1 modulate the expression of a number of chondrocyte-specific matrix molecules, the pronounced effects of these cytokines on the expression of the Sox9 gene strongly suggest that their principal effects on the chondrocyte phenotype is mediated by their regulation of Sox9 expression. Cloning of the regulatory sequences of the Sox9 gene may elucidate the precise mechanism(s) by which IL-1 and IGF-1 exert this control.
Several studies regarding chondrocyte survival in culture produced apparently conflicting results w34-38, 55-59x, perhaps because cells from different sources and at different stages of maturation were used. Whereas DES4 + .2 and 10W + .1 cells, which appear to express a prehypertrophic chondrocyte-like phenotype when cultured as monolayers, survived in low cell density cultures, they died rapidly by apoptosis when cultured at high cell density in the absence of serum or IGF-1. Addition of IL-1a to serum-free, confluent cultures of DES4 + .2 and 10W + .1 cells did not further stimulate apoptosis, but appeared to partially suppress the IGF-1-mediated positive effect on cell survival. Hence, IL-1a and IGF-1 had opposite and antagonistic effects on cell survival, IGF-1 being a cell survival factor. Several studies demonstrated that IGF-1 or insulin (at high enough concentrations to activate IGF-1 receptors) were effective in promoting the survival of cultured chondrocytes w34, 36, 38x. Thus, chondrocytes require exogenous signals to survive in culture, just like several other cell types w73, 74x, but it appears that the survival of prehypertrophic chondrocytes, unlike that of nearly all cell types investigated to date w74x, is independent of cell-to-cell communication. This agrees with recent findings with embryonic chick sternal chondrocytes w37x, which depended on the presence of serum or IGF-1.
Treatment of DES4 + .2 cells with 5-aza-CR induced DNA fragmentation irrespective of the presence of serum. One mechanism of DNA fragmentation involves the activation of endogenous endonucleases, hence 5-aza-CR may activate these DNA-degrading enzymes, leading to the activation of apoptosis of cultured chondrocytes.
In this study, we provide evidence that loss of chondrocyte phenotype by in vitro passage and after IL-1a treatment is linked to down-regulation of the expression of Sox-9, a factor that is required for chondrocyte differentiation and that IGF-1 relieves the IL-1a-induced inhibition of the expression of Sox-9, and hence promotes the chondrocyte phenotype.
Furthermore, our results demonstrate that IL-1a and IGF-1 affect chondrocyte apoptosis, IGF-1 being a chondrocyte survival factor. Given that IL-1 is present at elevated levels in inflammatory joint diseases, such as arthritis, and that it antagonizes the effects of IGF-1, which is available systemically or produced locally w28, 30, 31, 38x, the control of the expression of the Sox9 gene and the influence on cell survival by these two factors could limit the repair capacity of cartilage in inflammatory joint diseases.
